Skip to main content

ORMP

Oramed Pharmaceuticals Inc.

Company with tickers: ORMP

CIK
1176309
CUSIP
68403P203
Shares Outstanding
40,926,081
13F Activity (30d)
21 filings 19 filers

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$469,000
as of 2026-03-31
Fiscal Year Ended Cash Spent
2025-12-31 $4,741,000
2024-12-31 $2,484,000

Recent quarters

Quarter Ended Cash Spent
2025-12-31 $4,009,000 Δ
2025-09-30 $361,000 Δ
2024-12-31 $1,193,000 Δ